Guardant Health Inc (GH)

Cost of Revenue

$413.95M

TTM · Period ending: · USD

GH logo

GH Cost of Revenue

Latest reported$413.95M
GH TTM Cost of Revenue ($32.15M → $413.95M)
High-resolution chart · PNG

GH cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Guardant Health Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
413,947,000
379,203,000
349,007,000
327,108,000
308,010,000
299,226,000
289,799,000
274,723,000
257,848,000
239,275,000
227,052,000
211,656,000
194,538,000
177,417,000
156,325,000
142,626,000
132,946,000
126,146,000
122,912,000
117,897,000
108,268,000
100,776,000
92,535,000
85,966,000
83,293,000
77,691,000
70,720,000
62,829,000
54,366,000
47,492,000
43,210,000
38,411,000
37,021,000
34,497,000
32,148,500
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.